{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:27:15Z","timestamp":1773278835187,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41375-021-01400-4","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T13:08:10Z","timestamp":1632143290000},"page":"525-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gene therapy in a murine model of chronic eosinophilic leukemia-not otherwise specified (CEL-NOS)"],"prefix":"10.1038","volume":"36","author":[{"given":"Odelya E.","family":"Pagovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie M.","family":"Stiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna E.","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony R.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saparja","family":"Nag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-6839","authenticated-orcid":false,"given":"Ronald G.","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"1400_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ajh.24196","volume":"90","author":"J Gotlib","year":"2015","unstructured":"Gotlib J. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. Am J Hematol. 2015;90:1077\u201389.","journal-title":"Am J Hematol"},{"key":"1400_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/ajh.24880","volume":"92","author":"J Gotlib","year":"2017","unstructured":"Gotlib J. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017;92:1243\u201359.","journal-title":"Am J Hematol"},{"key":"1400_CR3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","volume":"129","author":"A Reiter","year":"2017","unstructured":"Reiter A, Gotlib J. Myeloid neoplasms with eosinophilia. Blood. 2017;129:704\u201314.","journal-title":"Blood"},{"key":"1400_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaci.2010.03.035","volume":"126","author":"MM Crane","year":"2010","unstructured":"Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol. 2010;126:179\u201381.","journal-title":"J Allergy Clin Immunol"},{"key":"1400_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/157339412799462512","volume":"8","author":"CH Dunphy","year":"2012","unstructured":"Dunphy CH. Chronic eosinophilic leukemia, not otherwise specified (CEL, NOS). Cancer Ther Rev. 2012;8:30\u20134.","journal-title":"Cancer Ther Rev"},{"key":"1400_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","volume":"124","author":"PU Ogbogu","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124:1319\u201325. e1313.","journal-title":"J Allergy Clin Immunol"},{"key":"1400_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ajh.23193","volume":"87","author":"G Helbig","year":"2012","unstructured":"Helbig G, Soja A, Bartkowska-Chrobok A, Kyrcz-Krzemien S. Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation. Am J Hematol. 2012;87:643\u20135.","journal-title":"Am J Hematol"},{"key":"1400_CR8","unstructured":"Part VII: Hematologic Malignancies. In: Hematology (Seventh Edition), edited by Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, et al. Elsevier, 2018, 763\u20131443 pp."},{"key":"1400_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2222.2008.03173.x","volume":"39","author":"BS Bochner","year":"2009","unstructured":"Bochner BS. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin Exp Allergy. 2009;39:317\u201324.","journal-title":"Clin Exp Allergy"},{"key":"1400_CR10","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.4049\/jimmunol.0801421","volume":"183","author":"DJ Song","year":"2009","unstructured":"Song DJ, Cho JY, Lee SY, Miller M, Rosenthal P, Soroosh P, et al. Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling. J Immunol. 2009;183:5333\u201341.","journal-title":"J Immunol"},{"key":"1400_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clim.2008.11.009","volume":"131","author":"DJ Song","year":"2009","unstructured":"Song DJ, Cho JY, Miller M, Strangman W, Zhang M, Varki A, et al. Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Clin Immunol. 2009;131:157\u201369.","journal-title":"Clin Immunol"},{"key":"1400_CR12","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1398-9995.2008.01709.x","volume":"63","author":"N Zimmermann","year":"2008","unstructured":"Zimmermann N, McBride ML, Yamada Y, Hudson SA, Jones C, Cromie KD, et al. Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy. 2008;63:1156\u201363.","journal-title":"Allergy"},{"key":"1400_CR13","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1182\/blood-2002-10-3058","volume":"101","author":"E Nutku","year":"2003","unstructured":"Nutku E, Aizawa H, Hudson SA, Bochner BS. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood. 2003;101:5014\u201320.","journal-title":"Blood"},{"key":"1400_CR14","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.bbrc.2005.08.202","volume":"336","author":"E Nutku","year":"2005","unstructured":"Nutku E, Hudson SA, Bochner BS. Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. Biochem Biophys Res Commun. 2005;336:918\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"1400_CR15","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1093\/glycob\/cwj008","volume":"16","author":"A Varki","year":"2006","unstructured":"Varki A, Angata T. Siglecs\u2013the major subfamily of I-type lectins. Glycobiology. 2006;16:1R\u201327R.","journal-title":"Glycobiology"},{"key":"1400_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1165\/rcmb.2007-0154OC","volume":"38","author":"E Nutku-Bilir","year":"2008","unstructured":"Nutku-Bilir E, Hudson SA, Bochner BS. Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways. Am J Respir Cell Mol Biol. 2008;38:121\u20134.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1400_CR17","doi-asserted-by":"publisher","first-page":"e68143","DOI":"10.1371\/journal.pone.0068143","volume":"8","author":"H Mao","year":"2013","unstructured":"Mao H, Kano G, Hudson SA, Brummet M, Zimmermann N, Zhu Z, et al. Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen. PLoS One. 2013;8:e68143.","journal-title":"PLoS One"},{"key":"1400_CR18","doi-asserted-by":"crossref","unstructured":"Camilleri AE, Nag S, Russo AR, Stiles KM, Crystal RG, Pagovich OE. Gene therapy for a murine model of eosinophilic esophagitis. Allergy. 2021;76:2740\u201352.","DOI":"10.1111\/all.14822"},{"key":"1400_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jviromet.2006.06.011","volume":"137","author":"JP Mayginnes","year":"2006","unstructured":"Mayginnes JP, Reed SE, Berg HG, Staley EM, Pintel DJ, Tullis GE. Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR. J Virol Methods. 2006;137:193\u2013204.","journal-title":"J Virol Methods"},{"key":"1400_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.12659\/MSMBR.883968","volume":"19","author":"F Wang","year":"2013","unstructured":"Wang F, Cui X, Wang M, Xiao W, Xu R. A reliable and feasible qPCR strategy for titrating AAV vectors. Med Sci Monit Basic Res. 2013;19:187\u201393.","journal-title":"Med Sci Monit Basic Res"},{"key":"1400_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7:118\u201330.","journal-title":"Nat Rev Immunol"},{"key":"1400_CR22","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, et al. Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174:6477\u201389.","journal-title":"J Immunol"},{"key":"1400_CR23","first-page":"90","volume":"28","author":"OE Pagovich","year":"2020","unstructured":"Pagovich OE, Camilleri AE, Nag S, Stiles KM, Crystal RG. AAV-mediated anti-eosinophil gene therapy for eosinophilic esophagitis. Mol Ther. 2020;28:90.","journal-title":"Mol Ther"},{"key":"1400_CR24","first-page":"161","volume":"26","author":"OE Pagovich","year":"2018","unstructured":"Pagovich OE, Russo AR, Whaley AS, Cronin S, Matsumura Y, Stiles KM, et al. Gene Therapy for chronic eosinophilic esophagitis. Mol Ther. 2018;26:161.","journal-title":"Mol Ther"},{"key":"1400_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","volume":"102","author":"AM Davidoff","year":"2003","unstructured":"Davidoff AM, Ng CY, Zhou J, Spence Y, Nathwani AC. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood. 2003;102:480\u20138.","journal-title":"Blood"},{"key":"1400_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ymthe.2005.09.003","volume":"13","author":"BP De","year":"2006","unstructured":"De BP, Heguy A, Hackett NR, Ferris B, Leopold PL, Lee J, et al. High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses. Mol Ther. 2006;13:67\u201376.","journal-title":"Mol Ther"},{"key":"1400_CR27","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/mt.2011.119","volume":"19","author":"JB Nietupski","year":"2011","unstructured":"Nietupski JB, Hurlbut GD, Ziegler RJ, Chu Q, Hodges BL, Ashe KM, et al. Systemic administration of AAV8-alpha-galactosidase A induces humoral tolerance in nonhuman primates despite low hepatic expression. Mol Ther. 2011;19:1999\u20132011.","journal-title":"Mol Ther"},{"key":"1400_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/sj.mt.6300355","volume":"16","author":"Z Wu","year":"2008","unstructured":"Wu Z, Sun J, Zhang T, Yin C, Yin F, Van Dyke T, et al. Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose. Mol Ther. 2008;16:280\u20139.","journal-title":"Mol Ther"},{"key":"1400_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/gt.2012.67","volume":"20","author":"AP Dane","year":"2013","unstructured":"Dane AP, Wowro SJ, Cunningham SC, Alexander IE. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes. Gene Ther. 2013;20:460\u20134.","journal-title":"Gene Ther"},{"key":"1400_CR30","doi-asserted-by":"publisher","first-page":"E172","DOI":"10.1002\/ajh.25811","volume":"95","author":"E Morsia","year":"2020","unstructured":"Morsia E, Reichard K, Pardanani A, Tefferi A, Gangat N. WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): a contemporary series from the Mayo Clinic. Am J Hematol 2020;95:E172\u2013E174.","journal-title":"Am J Hematol"},{"key":"1400_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","volume":"50","author":"C Curtis","year":"2016","unstructured":"Curtis C, Ogbogu P. Hypereosinophilic syndrome. Clin Rev Allergy Immunol. 2016;50:240\u201351.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1400_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.iac.2015.04.004","volume":"35","author":"L Falchi","year":"2015","unstructured":"Falchi L, Verstovsek S. Eosinophilia in hematologic disorders. Immunol Allergy Clin North Am. 2015;35:439\u201352.","journal-title":"Immunol Allergy Clin North Am"},{"key":"1400_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ajh.22062","volume":"86","author":"J Gotlib","year":"2011","unstructured":"Gotlib J. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol. 2011;86:677\u201388.","journal-title":"Am J Hematol"},{"key":"1400_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.clml.2012.09.018","volume":"13","author":"P Strati","year":"2013","unstructured":"Strati P, Cortes J, Faderl S, Kantarjian H, Verstovsek S. Long-term follow-up of patients with hypereosinophilic syndrome treated with Alemtuzumab, an anti-CD52 antibody. Clin Lymphoma Myeloma Leuk. 2013;13:287\u201391.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1400_CR35","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10875-011-9589-4","volume":"31","author":"SA Hudson","year":"2011","unstructured":"Hudson SA, Herrmann H, Du J, Cox P, Haddad el B, Butler B, et al. Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression. J Clin Immunol. 2011;31:1045\u201353.","journal-title":"J Clin Immunol"},{"key":"1400_CR36","unstructured":"Klion AD 55 - Eosinophilia. In: Keystone JS, Freedman DO, Kozarsky PE, Connor BA, Nothdurft HD (eds). Travel Medicine (Third Edition). Elsevier Inc.: London, 2013, pp. 501\u20139."},{"key":"1400_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7:255\u201366.","journal-title":"Nat Rev Immunol"},{"key":"1400_CR38","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","volume":"383","author":"ES Dellon","year":"2020","unstructured":"Dellon ES, Peterson KA, Murray JA, Falk GW, Gonsalves N, Chehade M, et al. Anti-Siglec-8 antibody for eosinophilic gastritis and duodenitis. N Engl J Med. 2020;383:1624\u201334.","journal-title":"N Engl J Med"},{"key":"1400_CR39","unstructured":"Siebenhaar F, Bonnekoh H, Hawro T, Hawro MO, Michaelis EG, Rasmussen HS, et al. Safety and efficacy data of AK002, an anti-siglec-8 monoclonal antibody, in patients with indolent systemic mastocytosis (ISM): Results from a first-in-human, open-label phase 1 study. 2019; https:\/\/www.allakos.com\/file.cfm\/59\/docs\/Levine_at_al_AAAAI_March_2020.pdf."},{"key":"1400_CR40","unstructured":"Allakos. Overview. 2020; https:\/\/www.allakos.com\/."},{"key":"1400_CR41","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.anai.2019.08.256","volume":"123","author":"S Altrichter","year":"2019","unstructured":"Altrichter S, Staubach P, Pasha M, Rasmussen H, Singh B, Chang A, et al. Clincial activity of AK002, an anti-siglec-8 antibody, in multiple forms of uncontrolled chronic urticaria. Ann Allergy Asthma Immunol. 2019;123:S27\u2013S28.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1400_CR42","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.anai.2019.08.361","volume":"123","author":"T Levine","year":"2019","unstructured":"Levine T, Tauber J, Nguyen Q, Anesi S, Chang P, Berdy G, et al. Clinical activity of AK002, an anti-siglec-8 antibody, in severe allergic conjunctivitis and comorbid atopic diseases. Ann Allergy, Asthma Immunol. 2019;123:S17.","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"1400_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bjh.14488","volume":"176","author":"NM Butt","year":"2017","unstructured":"Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176:553\u201372.","journal-title":"Br J Haematol"},{"key":"1400_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","volume":"130","author":"P Valent","year":"2012","unstructured":"Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130:607\u201312. e609.","journal-title":"J Allergy Clin Immunol"},{"key":"1400_CR45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1089\/hum.2012.245","volume":"24","author":"JB Rosenberg","year":"2013","unstructured":"Rosenberg JB, De BP, Hicks MJ, Janda KD, Kaminsky SM, Worgall S, et al. Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine. Hum Gene Ther. 2013;24:595\u2013603.","journal-title":"Hum Gene Ther"},{"key":"1400_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11882-011-0240-5","volume":"12","author":"J Celestin","year":"2012","unstructured":"Celestin J, Frieri M. Eosinophilic disorders in various diseases. Curr Allergy Asthma Rep. 2012;12:18\u201324.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1400_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.seminhematol.2012.01.006","volume":"49","author":"R Mejia","year":"2012","unstructured":"Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012;49:149\u201359.","journal-title":"Semin Hematol"},{"key":"1400_CR48","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/21678707.2015.1039511","volume":"3","author":"E Hastie","year":"2015","unstructured":"Hastie E, Samulski RJ. Recombinant adeno-associated virus vectors in the treatment of rare diseases. Expert Opin Orphan Drugs. 2015;3:675\u201389.","journal-title":"Expert Opin Orphan Drugs"},{"key":"1400_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2988","volume":"12","author":"F Mingozzi","year":"2011","unstructured":"Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet. 2011;12:341\u201355.","journal-title":"Nat Rev Genet"},{"key":"1400_CR50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.7326\/0003-4819-94-3-352","volume":"94","author":"W Franklin","year":"1981","unstructured":"Franklin W, Goetzl EJ. Total absence of eosinophils in a patient with an allergic disorder. Ann Intern Med. 1981;94:352\u20133.","journal-title":"Ann Intern Med"},{"key":"1400_CR51","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00134-011-2170-z","volume":"37","author":"K Abidi","year":"2011","unstructured":"Abidi K, Belayachi J, Derras Y, Khayari ME, Dendane T, Madani N, et al. Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med. 2011;37:1136\u201342.","journal-title":"Intensive Care Med"},{"key":"1400_CR52","doi-asserted-by":"publisher","first-page":"e42860","DOI":"10.1371\/journal.pone.0042860","volume":"7","author":"R Terradas","year":"2012","unstructured":"Terradas R, Grau S, Blanch J, Riu M, Saballs P, Castells X, et al. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PLoS ONE. 2012;7:e42860.","journal-title":"PLoS ONE"},{"key":"1400_CR53","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/all.12169","volume":"68","author":"GJ Gleich","year":"2013","unstructured":"Gleich GJ, Klion AD, Lee JJ, Weller PF. The consequences of not having eosinophils. Allergy. 2013;68:829\u201335.","journal-title":"Allergy"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01400-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T21:06:02Z","timestamp":1675717562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01400-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1400"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01400-4","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}